Profile	GDS4460 / 208964_s_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	67.8	62
GSM803589	patient 7, baseline	53	57
GSM803592	patient 8, baseline	82.3	64
GSM803595	patient 10, baseline	688.7	93
GSM803598	patient 11, baseline	81.2	65
GSM803601	patient 12, baseline	74	62
GSM803604	patient 13, baseline	132.6	73
GSM803607	patient 14, baseline	80.4	64
GSM803610	patient 15, baseline	74.7	64
GSM803613	patient 16, baseline	118.8	71
GSM803587	patient 6, arm treated with pimecrolimus	126.6	72
GSM803590	patient 7, arm treated with pimecrolimus	72.8	63
GSM803593	patient 8, arm treated with pimecrolimus	96.3	67
GSM803605	patient 13, arm treated with pimecrolimus	100.9	69
GSM803608	patient 14, arm treated with pimecrolimus	136.1	73
GSM803599	patient 11, arm treated with pimecrolimus	221.8	80
GSM803611	patient 15, arm treated with pimecrolimus	64.5	61
GSM803614	patient 16, arm treated with pimecrolimus	114.6	70
GSM803602	patient 12, arm treated with pimecrolimus	103.7	68
GSM803596	patient 10, arm treated with pimecrolimus	665.5	93
GSM803591	patient 8, arm treated with betamethasone	119.4	71
GSM803609	patient 15, arm treated with betamethasone	146.6	74
GSM803597	patient 11, arm treated with betamethasone	375.1	87
GSM803585	patient 6, arm treated with betamethasone	103	68
GSM803603	patient 13, arm treated with betamethasone	781.3	94
GSM803612	patient 16, arm treated with betamethasone	127.6	71
GSM803588	patient 7, arm treated with betamethasone	188.3	77
GSM803594	patient 10, arm treated with betamethasone	2376.5	98
GSM803600	patient 12, arm treated with betamethasone	73	62
GSM803606	patient 14, arm treated with betamethasone	152.5	74